WOLVERINE ASSET MANAGEMENT LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 58 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$15,000
+150.0%
6,7150.0%0.00%
Q4 2016$6,000
-14.3%
6,7150.0%0.00%
Q3 2016$7,000
-22.2%
6,7150.0%0.00%
Q2 2016$9,0000.0%6,7150.0%0.00%
Q1 2016$9,000
-18.2%
6,7150.0%0.00%
Q4 2015$11,000
-26.7%
6,7150.0%0.00%
Q3 2015$15,000
-16.7%
6,7150.0%0.00%
Q2 2015$18,000
-96.0%
6,715
-87.9%
0.00%
-100.0%
Q4 2013$447,00055,4390.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders